GYRE

Gyre TherapeuticsA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

GYRE vs peer average

84/100

GYRE vs. peer average (A vs. C)

Grade spread

A 1 · B 2 · C 2 · D 3 · F 1

Graded peers loaded

Coverage

10 graded

100% of tracked

Peer overview

ALT is the first available peer comparator.

Loose same-sector small-cap biopharma comp for event-driven trading and regulatory optionality; useful for sentiment framing, not a direct operating analog.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerALTAltimmune

GYRE

Gyre Therapeutics

ALT

Altimmune

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Constructive

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs ALT

GYRE / ALT

Grade Position

Above peers

GYRE vs. peer average (A vs. C)

84/100

Momentum

GYRE

Value

GYRE

Sentiment

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs GYRE

20/100

60/100

80/100

ProKidney Corp Class A Common

40/100

AGMB

AgomAb Therapeutics NV ADR

N/A

ALT is the first peer returned for this comparison set.